Evaluating the Value of a Payer Contract

Published in Government Relations on June 24, 2025

By Melanie Ewald, VP of Payer Relations and Reimbursement, VGM  

In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort. 

DMEPOS providers continue to navigate a minefield of challenges such as shrinking margins, regulatory complexities, and challenges with payer reimbursement and contracting. Deciding whether to enter or remain in-network with a given payer is one of the most critical decisions DME providers will make. Getting in-network under the right contract can expand access to more patients and thus increase revenue.  

Entering or remaining in the wrong contract can chip away at your profitability. You are not required to accept every contract offered to you. Consider the following as you evaluate new and existing contract opportunities. 

Does the contract bring in new patients? Does it increase your ability to say “Yes” more often to referral sources? Are you getting paid more than what you paid to acquire the product? Do you require profit on every transaction? Each of these points is important on their own; however, even when combined, they do not necessarily make a contract worth having or viable.  

Viable long-term contracts provide for at least the following: 

  • Reimbursement covers ALL costs, not just product acquisition. 
  • Policies are actually followed as prescribed in the contract and provider manuals. 
  • Transparent notice process for contract amendments and policy updates. 
  • Clearly defined resolution process for when issues arise. 

Pay close attention to arrangements that may have hidden profit diminishers such as: 

  • Administratively burdensome requirements that increase your costs. i.e., employee time required to handle frequent prior authorizations and denial management due to unclear documentation requirements and unclear appeals processes. 
  • High volume low-reimbursement arrangements may provide access to more patients, but will not fix profit margins and may drain critical resources. 

Today’s payer environment is such that not every contract is worth having and some could ultimately be detrimental to your business. Each contract, particularly those requiring extensive effort and resources to execute, should be evaluated closely with profitability, operational efficiency, and strategic fit in mind. 

From Our Experts

Congratulations to CAMPS On This Important Legislative Victory thumbnail Congratulations to CAMPS On This Important Legislative Victory The signing of AB 1794 is another reminder of the critical role state associations play in shaping healthcare policy, removing barriers to patient care, and ensuring providers have a seat at the table when important decisions are made. Legislative successes like this do not happen by accident. They are the result of engaged members, strong advocacy efforts, and collaboration with policymakers to address real-world challenges facing providers and the patients they serve. August Recess Recap: Building Relationships, Advancing Advocacy thumbnail August Recess Recap: Building Relationships, Advancing Advocacy As Congress worked through the August recess, the VGM Government Relations team remained actively engaged in securing meetings and building relationships with legislators, candidates, and key congressional staff across the country. This summer, the team made a strategic decision to focus getting a strong balance between Republican and Democratic offices, recognizing the importance of broadening support for DMEPOS priorities and ensuring policymakers from both parties understand the challenges.. Introducing Patient Voices: Access to HME Matters thumbnail Introducing Patient Voices: Access to HME Matters The VGM Government Relations team is excited to announce Patient Voices: Access to HME Matters, a new way for patients, providers, vendors, caregivers, and industry partners to share their experiences with home medical equipment. Every story matters. AAHomecare Survey Results of RID Program thumbnail AAHomecare Survey Results of RID Program Thank you to AAHomecare for initiating this important survey demonstrating the significant risks to the DMEPOS industry should Remote Item Delivery Competitive Bid Program (RID CBP) Round 2028 move forward as is. VGM Group is proud to support the survey efforts to maximize provider participation. See below for the survey summary and analysis. Competitive Bidding Update: NPEast and NPWest Updating Licensure Requirement Information for Competitive Bidding Product Categories thumbnail Competitive Bidding Update: NPEast and NPWest Updating Licensure Requirement Information for Competitive Bidding Product Categories Per the Remote Item Delivery Competitive Bidding Program (RID CBP) Round 2028 requirements, bidders must meet all business and product category licensure requirements across every state, the District of Columbia, and the U.S. territories to be eligible to be a contract winner. New CMS Nationwide Probationary Prior Authorization Requirement for Newly Enrolled Suppliers of Certain DMEPOS Items thumbnail New CMS Nationwide Probationary Prior Authorization Requirement for Newly Enrolled Suppliers of Certain DMEPOS Items On Sept. 2, 2026, CMS introduced the Probationary Prior Authorization (PPA) program that will place newly enrolled DMEPOS Suppliers and those undergoing 100% change in ownership on a one-year probationary period. Effective Oct. 15, impacted suppliers will be required to submit a prior authorization request for specific HCPCS codes. OIG Report Signals Increased Fraud Oversight for DMEPOS Suppliers thumbnail OIG Report Signals Increased Fraud Oversight for DMEPOS Suppliers The HHS Office of Inspector General (OIG) recently released a white paper examining ongoing Medicare fraud involving durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). Preparing for Increased Audit Activity: How VGM Group and The van Halem Group Can Help thumbnail Preparing for Increased Audit Activity: How VGM Group and The van Halem Group Can Help The recent HHS Office of Inspector General (OIG) report on DMEPOS fraud signals that CMS is likely to increase oversight activities across the industry. The report calls for enhanced supplier enrollment screening, more aggressive medical reviews, expanded use of artificial intelligence and data analytics, greater physician order verification, and increased scrutiny of supplier ownership and billing practices.